Anis Karimpour-Fard
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 12 | 2026 | 695 | 1.230 |
Why?
| | Computational Biology | 9 | 2015 | 675 | 0.840 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2025 | 357 | 0.820 |
Why?
| | Protein Interaction Mapping | 3 | 2008 | 105 | 0.580 |
Why?
| | Ventricular Remodeling | 4 | 2025 | 283 | 0.550 |
Why?
| | Software | 2 | 2015 | 673 | 0.530 |
Why?
| | Myocytes, Cardiac | 5 | 2026 | 542 | 0.500 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 26 | 0.470 |
Why?
| | DNA Copy Number Variations | 2 | 2018 | 189 | 0.430 |
Why?
| | Hibernation | 5 | 2014 | 82 | 0.410 |
Why?
| | Proteomics | 6 | 2015 | 1202 | 0.410 |
Why?
| | Caloric Restriction | 2 | 2026 | 133 | 0.390 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2026 | 188 | 0.380 |
Why?
| | Phylogeny | 4 | 2014 | 921 | 0.370 |
Why?
| | Comparative Genomic Hybridization | 2 | 2018 | 28 | 0.360 |
Why?
| | Gene Expression Profiling | 10 | 2021 | 1790 | 0.350 |
Why?
| | Sciuridae | 5 | 2014 | 152 | 0.340 |
Why?
| | Escherichia coli | 6 | 2012 | 831 | 0.340 |
Why?
| | Biomarkers | 8 | 2026 | 4329 | 0.310 |
Why?
| | Multigene Family | 3 | 2008 | 209 | 0.290 |
Why?
| | Cluster Analysis | 6 | 2021 | 494 | 0.290 |
Why?
| | Proteome | 3 | 2023 | 520 | 0.280 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2021 | 70 | 0.270 |
Why?
| | Sequence Analysis, Protein | 1 | 2007 | 32 | 0.260 |
Why?
| | Seasons | 5 | 2014 | 535 | 0.260 |
Why?
| | Data Collection | 1 | 2010 | 647 | 0.260 |
Why?
| | Superoxide Dismutase | 2 | 2020 | 307 | 0.250 |
Why?
| | Ventricular Function, Left | 2 | 2025 | 541 | 0.250 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 13 | 0.250 |
Why?
| | Metabolic Networks and Pathways | 5 | 2017 | 175 | 0.250 |
Why?
| | DNA Helicases | 2 | 2021 | 138 | 0.250 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2012 | 751 | 0.240 |
Why?
| | Genome, Bacterial | 4 | 2012 | 122 | 0.230 |
Why?
| | Algorithms | 3 | 2008 | 1843 | 0.230 |
Why?
| | Iodide Peroxidase | 1 | 2026 | 34 | 0.230 |
Why?
| | Signal Transduction | 4 | 2023 | 5234 | 0.220 |
Why?
| | Bacterial Proteins | 2 | 2010 | 976 | 0.220 |
Why?
| | Genome | 4 | 2014 | 307 | 0.220 |
Why?
| | Amniotic Fluid | 2 | 2024 | 75 | 0.210 |
Why?
| | Escherichia coli Proteins | 3 | 2012 | 200 | 0.210 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 189 | 0.210 |
Why?
| | Models, Biological | 2 | 2008 | 1758 | 0.200 |
Why?
| | Trophoblasts | 1 | 2026 | 219 | 0.190 |
Why?
| | Fetal Growth Retardation | 2 | 2026 | 592 | 0.190 |
Why?
| | Arousal | 3 | 2012 | 157 | 0.190 |
Why?
| | Fetal Blood | 1 | 2024 | 325 | 0.180 |
Why?
| | DNA-Binding Proteins | 3 | 2021 | 1467 | 0.180 |
Why?
| | Heart Failure | 3 | 2023 | 2323 | 0.170 |
Why?
| | Species Specificity | 6 | 2008 | 542 | 0.170 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 144 | 0.170 |
Why?
| | Perforator Flap | 1 | 2022 | 41 | 0.170 |
Why?
| | Transcriptome | 4 | 2021 | 1066 | 0.170 |
Why?
| | Bleomycin | 2 | 2020 | 255 | 0.170 |
Why?
| | Heart Defects, Congenital | 2 | 2021 | 920 | 0.170 |
Why?
| | Focal Adhesions | 1 | 2021 | 47 | 0.170 |
Why?
| | Hypotension | 1 | 2022 | 125 | 0.170 |
Why?
| | Animals | 26 | 2026 | 38030 | 0.170 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 26 | 0.170 |
Why?
| | Prostatic Neoplasms | 2 | 2021 | 972 | 0.160 |
Why?
| | Heart Rate | 1 | 2025 | 844 | 0.160 |
Why?
| | Milrinone | 1 | 2021 | 26 | 0.160 |
Why?
| | Genetic Variation | 4 | 2018 | 992 | 0.160 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2025 | 252 | 0.160 |
Why?
| | Phosphorylation | 3 | 2021 | 1717 | 0.160 |
Why?
| | Evolution, Molecular | 4 | 2014 | 501 | 0.160 |
Why?
| | Heart Transplantation | 2 | 2018 | 679 | 0.150 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 219 | 0.150 |
Why?
| | Receptors, Androgen | 1 | 2021 | 149 | 0.150 |
Why?
| | Biological Products | 1 | 2023 | 257 | 0.150 |
Why?
| | Mammaplasty | 1 | 2022 | 148 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 94 | 0.150 |
Why?
| | RNA Interference | 1 | 2021 | 470 | 0.150 |
Why?
| | Humans | 37 | 2026 | 145625 | 0.140 |
Why?
| | Keloid | 1 | 2019 | 8 | 0.140 |
Why?
| | Dermis | 1 | 2019 | 31 | 0.140 |
Why?
| | Myocardium | 2 | 2017 | 948 | 0.140 |
Why?
| | Chromatography, Liquid | 3 | 2016 | 452 | 0.140 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 23 | 0.140 |
Why?
| | Fever | 1 | 2020 | 320 | 0.140 |
Why?
| | RNA, Messenger | 6 | 2024 | 2783 | 0.140 |
Why?
| | Mosaicism | 1 | 2018 | 67 | 0.140 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2591 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2026 | 1212 | 0.130 |
Why?
| | Female | 26 | 2026 | 79080 | 0.130 |
Why?
| | Fluorouracil | 1 | 2019 | 231 | 0.130 |
Why?
| | Inflammation | 2 | 2020 | 2915 | 0.130 |
Why?
| | Serum | 1 | 2018 | 58 | 0.130 |
Why?
| | Cardiomyopathies | 1 | 2021 | 339 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2021 | 564 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2023 | 598 | 0.130 |
Why?
| | Heart Ventricles | 2 | 2021 | 762 | 0.130 |
Why?
| | Databases, Genetic | 2 | 2015 | 239 | 0.120 |
Why?
| | Muscle Proteins | 2 | 2025 | 242 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2020 | 311 | 0.120 |
Why?
| | Mice | 11 | 2026 | 18266 | 0.120 |
Why?
| | Pregnancy | 6 | 2026 | 7217 | 0.120 |
Why?
| | Reference Values | 2 | 2008 | 787 | 0.120 |
Why?
| | Specimen Handling | 1 | 2018 | 178 | 0.120 |
Why?
| | Models, Genetic | 3 | 2008 | 537 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 333 | 0.120 |
Why?
| | Plasma | 1 | 2018 | 222 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 300 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2018 | 543 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 574 | 0.110 |
Why?
| | Energy Metabolism | 3 | 2023 | 930 | 0.110 |
Why?
| | Calcium | 1 | 2021 | 1181 | 0.110 |
Why?
| | Ethanol | 2 | 2012 | 629 | 0.110 |
Why?
| | Hylobates | 1 | 2014 | 8 | 0.110 |
Why?
| | Karyotype | 1 | 2014 | 18 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2228 | 0.100 |
Why?
| | Down-Regulation | 2 | 2021 | 612 | 0.100 |
Why?
| | Fetoscopy | 2 | 2026 | 38 | 0.100 |
Why?
| | Fetus | 1 | 2018 | 798 | 0.100 |
Why?
| | Phenotype | 3 | 2025 | 3186 | 0.100 |
Why?
| | Case-Control Studies | 4 | 2024 | 3633 | 0.100 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2014 | 119 | 0.100 |
Why?
| | Heart | 2 | 2021 | 624 | 0.100 |
Why?
| | Metabolomics | 2 | 2016 | 737 | 0.090 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 31 | 0.090 |
Why?
| | Mutation | 5 | 2023 | 4082 | 0.090 |
Why?
| | Lipectomy | 1 | 2012 | 9 | 0.090 |
Why?
| | Drug Tolerance | 1 | 2012 | 99 | 0.090 |
Why?
| | Fasting | 1 | 2014 | 280 | 0.090 |
Why?
| | Amino Acids | 1 | 2016 | 513 | 0.090 |
Why?
| | Male | 18 | 2026 | 73014 | 0.090 |
Why?
| | Subcutaneous Fat | 1 | 2012 | 79 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2011 | 24 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 751 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 163 | 0.080 |
Why?
| | Biomarkers, Tumor | 2 | 2023 | 1334 | 0.080 |
Why?
| | Abdomen | 1 | 2012 | 140 | 0.080 |
Why?
| | Gene Duplication | 3 | 2007 | 67 | 0.080 |
Why?
| | Gluconeogenesis | 1 | 2011 | 81 | 0.080 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 149 | 0.080 |
Why?
| | Dog Diseases | 1 | 2012 | 140 | 0.080 |
Why?
| | Bacterial Infections | 1 | 2012 | 246 | 0.080 |
Why?
| | Gene Dosage | 2 | 2010 | 146 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2411 | 0.080 |
Why?
| | Reproducibility of Results | 4 | 2018 | 3396 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 721 | 0.080 |
Why?
| | Ligases | 1 | 2010 | 38 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 239 | 0.080 |
Why?
| | Sigma Factor | 1 | 2010 | 47 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 929 | 0.080 |
Why?
| | Markov Chains | 1 | 2010 | 128 | 0.080 |
Why?
| | Pancreas | 1 | 2012 | 342 | 0.080 |
Why?
| | Glycolysis | 1 | 2011 | 341 | 0.070 |
Why?
| | Oligonucleotides | 1 | 2010 | 154 | 0.070 |
Why?
| | Child | 8 | 2022 | 22638 | 0.070 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 319 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2010 | 202 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 494 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 611 | 0.070 |
Why?
| | Prospective Studies | 4 | 2024 | 8087 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4565 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2131 | 0.070 |
Why?
| | Escherichia coli K12 | 1 | 2008 | 7 | 0.070 |
Why?
| | Genetic Enhancement | 1 | 2008 | 5 | 0.070 |
Why?
| | Stroke Volume | 2 | 2025 | 651 | 0.070 |
Why?
| | Placenta | 2 | 2026 | 794 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3538 | 0.070 |
Why?
| | Biostatistics | 1 | 2008 | 19 | 0.070 |
Why?
| | DNA Repair | 1 | 2010 | 254 | 0.070 |
Why?
| | Adiposity | 1 | 2012 | 531 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2021 | 887 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 899 | 0.060 |
Why?
| | Computer Simulation | 2 | 2008 | 1014 | 0.060 |
Why?
| | Protein Engineering | 1 | 2008 | 122 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 382 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2008 | 505 | 0.060 |
Why?
| | Shigella flexneri | 1 | 2007 | 15 | 0.060 |
Why?
| | Genomics | 1 | 2012 | 851 | 0.060 |
Why?
| | Pneumonia | 1 | 2012 | 633 | 0.060 |
Why?
| | Primates | 1 | 2007 | 133 | 0.060 |
Why?
| | Likelihood Functions | 1 | 2007 | 138 | 0.060 |
Why?
| | Databases, Protein | 1 | 2007 | 88 | 0.060 |
Why?
| | Macaca mulatta | 1 | 2007 | 187 | 0.060 |
Why?
| | Pregnancy Trimester, Second | 1 | 2026 | 91 | 0.060 |
Why?
| | DNA Probes | 1 | 2006 | 57 | 0.060 |
Why?
| | Prognosis | 3 | 2026 | 4331 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2910 | 0.060 |
Why?
| | Models, Statistical | 2 | 2008 | 667 | 0.060 |
Why?
| | Placentation | 1 | 2026 | 52 | 0.060 |
Why?
| | Triiodothyronine | 1 | 2026 | 55 | 0.060 |
Why?
| | Forecasting | 1 | 2007 | 386 | 0.060 |
Why?
| | Thyroid Hormones | 1 | 2026 | 69 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 6021 | 0.060 |
Why?
| | Liver | 1 | 2014 | 1859 | 0.060 |
Why?
| | Genome, Human | 1 | 2007 | 425 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2018 | 4112 | 0.050 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 39 | 0.050 |
Why?
| | Sequence Analysis, DNA | 4 | 2010 | 771 | 0.050 |
Why?
| | Biopsy | 2 | 2019 | 1073 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 116 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1491 | 0.050 |
Why?
| | Models, Theoretical | 1 | 2007 | 558 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2533 | 0.050 |
Why?
| | Potassium Channels | 1 | 2025 | 148 | 0.050 |
Why?
| | Biofilms | 1 | 2007 | 288 | 0.050 |
Why?
| | Echocardiography | 2 | 2021 | 645 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 20 | 0.050 |
Why?
| | Phosphoproteins | 2 | 2019 | 319 | 0.050 |
Why?
| | Child, Preschool | 4 | 2021 | 11888 | 0.050 |
Why?
| | Adult | 6 | 2026 | 40821 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 165 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 190 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 109 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2097 | 0.050 |
Why?
| | Rats | 2 | 2021 | 5574 | 0.050 |
Why?
| | Sarcomeres | 1 | 2023 | 100 | 0.050 |
Why?
| | Up-Regulation | 2 | 2018 | 840 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2021 | 456 | 0.050 |
Why?
| | Epigastric Arteries | 1 | 2022 | 39 | 0.040 |
Why?
| | Endopeptidase K | 1 | 2021 | 17 | 0.040 |
Why?
| | Lung | 3 | 2024 | 4119 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 766 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2835 | 0.040 |
Why?
| | Ribonucleases | 1 | 2021 | 49 | 0.040 |
Why?
| | Light Coagulation | 1 | 2021 | 10 | 0.040 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 32 | 0.040 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1429 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 125 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1795 | 0.040 |
Why?
| | DNA Primers | 2 | 2012 | 487 | 0.040 |
Why?
| | Cardiac Output, Low | 1 | 2021 | 53 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1176 | 0.040 |
Why?
| | Body Temperature | 2 | 2012 | 227 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | Cardiotonic Agents | 1 | 2021 | 94 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 51 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 187 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 87 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 226 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2064 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 211 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 295 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 179 | 0.040 |
Why?
| | Mass Spectrometry | 2 | 2014 | 728 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 134 | 0.040 |
Why?
| | Hominidae | 2 | 2014 | 89 | 0.040 |
Why?
| | Infant | 3 | 2020 | 10093 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2020 | 140 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 34 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 291 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1293 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 441 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2021 | 746 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 112 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2026 | 3121 | 0.030 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 41 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1709 | 0.030 |
Why?
| | Cell Cycle | 1 | 2021 | 595 | 0.030 |
Why?
| | Transcription Factors | 2 | 2019 | 1728 | 0.030 |
Why?
| | Freezing | 1 | 2018 | 84 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 409 | 0.030 |
Why?
| | Cohort Studies | 2 | 2022 | 6045 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11744 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 973 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 40 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 17 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1878 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2016 | 61 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 104 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 36 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 51 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 224 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 905 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2112 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 2007 | 175 | 0.030 |
Why?
| | Pan troglodytes | 2 | 2007 | 62 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2809 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 217 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1125 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 889 | 0.030 |
Why?
| | Middle Aged | 4 | 2025 | 36359 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 10840 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1866 | 0.030 |
Why?
| | Hot Temperature | 1 | 2018 | 396 | 0.030 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 22 | 0.030 |
Why?
| | Retroelements | 1 | 2014 | 50 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1156 | 0.030 |
Why?
| | Immunologic Memory | 1 | 2016 | 369 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 225 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 313 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 22451 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2016 | 511 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2021 | 2497 | 0.020 |
Why?
| | Cadherins | 1 | 2015 | 201 | 0.020 |
Why?
| | Sirtuin 3 | 1 | 2014 | 60 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 503 | 0.020 |
Why?
| | Acetylation | 1 | 2014 | 262 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 613 | 0.020 |
Why?
| | CD146 Antigen | 1 | 2012 | 38 | 0.020 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2012 | 11 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2012 | 90 | 0.020 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6449 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 76 | 0.020 |
Why?
| | Mycoplasma pneumoniae | 1 | 2012 | 54 | 0.020 |
Why?
| | Peptide Library | 1 | 2012 | 91 | 0.020 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2012 | 56 | 0.020 |
Why?
| | Skinfold Thickness | 1 | 2012 | 43 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2014 | 269 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2012 | 46 | 0.020 |
Why?
| | Cystathionine beta-Synthase | 1 | 2012 | 65 | 0.020 |
Why?
| | Receptors, Complement 3b | 1 | 2012 | 83 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 196 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 317 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 125 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17291 | 0.020 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2012 | 98 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2011 | 58 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 147 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 324 | 0.020 |
Why?
| | Thermogenesis | 1 | 2011 | 45 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 184 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 516 | 0.020 |
Why?
| | Hindlimb | 1 | 2011 | 128 | 0.020 |
Why?
| | Exons | 1 | 2012 | 361 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 140 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 777 | 0.020 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 16 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2010 | 27 | 0.020 |
Why?
| | Glycine | 1 | 2011 | 184 | 0.020 |
Why?
| | Young Adult | 2 | 2021 | 14240 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 112 | 0.020 |
Why?
| | Gene Library | 1 | 2010 | 121 | 0.020 |
Why?
| | Arginine | 1 | 2011 | 263 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2010 | 87 | 0.020 |
Why?
| | NAD | 1 | 2010 | 80 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 507 | 0.020 |
Why?
| | Genes | 1 | 2010 | 215 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 377 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 443 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5397 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 674 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 384 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 989 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1979 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 525 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 295 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2436 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2010 | 337 | 0.020 |
Why?
| | Radiographic Image Enhancement | 1 | 2008 | 56 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2008 | 124 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 533 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2857 | 0.020 |
Why?
| | Genetic Diseases, Inborn | 1 | 2007 | 45 | 0.020 |
Why?
| | Neutrophils | 1 | 2012 | 1132 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2119 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1075 | 0.010 |
Why?
| | Mammography | 1 | 2008 | 172 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2007 | 155 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1526 | 0.010 |
Why?
| | Heat-Shock Response | 1 | 2006 | 78 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2079 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 319 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2004 | 15 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2004 | 22 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 2004 | 7 | 0.010 |
Why?
| | Aged | 1 | 2025 | 26251 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1030 | 0.010 |
Why?
| | Environment | 1 | 2006 | 295 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2004 | 116 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3321 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 269 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2006 | 388 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 526 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 333 | 0.010 |
Why?
| | Biomedical Research | 1 | 2007 | 724 | 0.010 |
Why?
| | Biological Evolution | 1 | 2004 | 471 | 0.010 |
Why?
| | Alcoholism | 1 | 2006 | 830 | 0.010 |
Why?
| | Sleep | 1 | 2006 | 896 | 0.010 |
Why?
| | Proteins | 1 | 2004 | 1021 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7079 | 0.010 |
Why?
|
|
Karimpour-Fard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|